scholarly article | Q13442814 |
review article | Q7318358 |
P356 | DOI | 10.1002/1096-9071(200007)61:3<403::AID-JMV21>3.0.CO;2-5 |
P698 | PubMed publication ID | 10861654 |
P2093 | author name string | Keeffe EB | |
P2860 | cites work | The anti-hepatitis B virus activities, cytotoxicities, and anabolic profiles of the (-) and (+) enantiomers of cis-5-fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine | Q28327158 |
Improved outcome of orthotopic liver transplantation for chronic hepatitis B cirrhosis with aggressive passive immunization | Q30468279 | ||
Interferon in the management of chronic hepatitis B. | Q40891677 | ||
Prophylaxis against hepatitis B recurrence following liver transplantation using combination lamivudine and hepatitis B immune globulin | Q42540557 | ||
A one-year trial of lamivudine for chronic hepatitis B. Asia Hepatitis Lamivudine Study Group. | Q42541246 | ||
Liver transplantation in Asian patients with chronic hepatitis B. | Q44675890 | ||
Lamivudine treatment for acute hepatitis B after liver transplantation | Q44704413 | ||
Efficacy of lamivudine in controlling hepatitis B virus recurrence after liver transplantation | Q45754826 | ||
Famciclovir treatment of hepatitis B virus recurrence after liver transplantation: a pilot study | Q45759880 | ||
A pretransplant infection with precore mutants of hepatitis B virus does not influence the outcome of orthotopic liver transplantation in patients on high dose anti-hepatitis B virus surface antigen immunoprophylaxis | Q45761265 | ||
Incidence and clinical consequences of surface and polymerase gene mutations in liver transplant recipients on hepatitis B immunoglobulin. | Q46990265 | ||
Short-term cyclosporine induces a remission of autoimmune hepatitis in children. | Q53347844 | ||
Multicenter study of lamivudine therapy for hepatitis B after liver transplantation. Lamivudine Transplant Group. | Q53933482 | ||
P433 | issue | 3 | |
P921 | main subject | lamivudine | Q422631 |
liver transplantation | Q1368191 | ||
end-stage liver disease | Q54974362 | ||
chronic hepatitis | Q62019625 | ||
P304 | page(s) | 403-408 | |
P577 | publication date | 2000-07-01 | |
P1433 | published in | Journal of Medical Virology | Q15716684 |
P1476 | title | End-stage liver disease and liver transplantation: role of lamivudine therapy in patients with chronic hepatitis B. | |
P478 | volume | 61 |
Q34687438 | Chronic hepatitis B: current and future treatment options |
Q44461529 | Cost-effective and safe ambulatory long-term immunoprophylaxis with intramuscular instead of intravenous hepatitis B immunoglobulin to prevent reinfection after orthotopic liver transplantation |
Q35110095 | Experience with lamivudine therapy for hepatitis B virus infection before and after liver transplantation, and review of the literature |
Q33959006 | Management of viral hepatitis B. |
Q35543577 | Nucleoside analogues and other antivirals for treatment of hepatitis B in the peritransplant period |
Q35156150 | Reestablishment of active immunity against HBV graft reinfection after liver transplantation for HBV-related end stage liver disease. |
Q46712921 | Timing of lamivudine administration according to Child class in patients with decompensated cirrhosis |